In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon

doi:10.1084/jem.166.3.798

This Article

	Full Text (PDF, 390K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Jacob, C. O.
	Articles by McDevitt, H. O.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Jacob, C. O.
	Articles by McDevitt, H. O.


Social Bookmarking

	What's this?

ARTICLES

In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon

CO Jacob, PH van der Meide and HO McDevitt

The (NZB X NZW)F1 mouse is recognized as an important animal model of the human disease systemic lupus erythematosus (SLE). Groups of NZB/W F1 mice were treated either with IFN-gamma or with PBS. The results demonstrate that IFN-treated animals have accelerated development of fatal immune complex glomerulonephritis relative to age-matched controls. On the other hand, administration of mAbs specific for IFN- gamma to such mice from 4 to 7 mo of age resulted in significant remission. Development of both proteinuria and anti-DNA antibodies were delayed and survival at 11 mo was increased from less than 20% to 95% in treated mice relative to controls (p less than or equal to 0.001). These findings may have therapeutic implications for the treatment of SLE.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Rivas, M. N., Weatherly, K., Hazzan, M., Vokaer, B., Dremier, S., Gaudray, F., Goldman, M., Salmon, I., Braun, M. Y. (2009). Reviving Function in CD4+ T Cells Adapted to Persistent Systemic Antigen. J. Immunol. 183: 4284-4291 [Abstract] [Full Text]
Jacob, C. O., Zhu, J., Armstrong, D. L., Yan, M., Han, J., Zhou, X. J., Thomas, J. A., Reiff, A., Myones, B. L., Ojwang, J. O., Kaufman, K. M., Klein-Gitelman, M., McCurdy, D., Wagner-Weiner, L., Silverman, E., Ziegler, J., Kelly, J. A., Merrill, J. T., Harley, J. B., Ramsey-Goldman, R., Vila, L. M., Bae, S.-C., Vyse, T. J., Gilkeson, G. S., Gaffney, P. M., Moser, K. L., Langefeld, C. D., Zidovetzki, R., Mohan, C. (2009). Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 106: 6256-6261 [Abstract] [Full Text]
Jacob, N., Yang, H., Pricop, L., Liu, Y., Gao, X., Zheng, S. G., Wang, J., Gao, H.-X., Putterman, C., Koss, M. N., Stohl, W., Jacob, C. O. (2009). Accelerated Pathological and Clinical Nephritis in Systemic Lupus Erythematosus-Prone New Zealand Mixed 2328 Mice Doubly Deficient in TNF Receptor 1 and TNF Receptor 2 via a Th17-Associated Pathway. J. Immunol. 182: 2532-2541 [Abstract] [Full Text]
Sharabi, A., Mozes, E. (2008). The Suppression of Murine Lupus by a Tolerogenic Peptide Involves Foxp3-Expressing CD8 Cells That Are Required for the Optimal Induction and Function of Foxp3-Expressing CD4 Cells. J. Immunol. 181: 3243-3251 [Abstract] [Full Text]
Yamauchi, M., Hashimoto, M., Ichiyama, K., Yoshida, R., Hanada, T., Muta, T., Komune, S., Kobayashi, T., Yoshimura, A. (2007). Ifi202, an IFN-inducible candidate gene for lupus susceptibility in NZB/W F1 mice, is a positive regulator for NF-{kappa}B activation in dendritic cells. Int Immunol 0: dxm054v1- [Abstract] [Full Text]
Waeckerle-Men, Y., Starke, A., Wuthrich, R. P. (2007). PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+cytotoxic T cells. Nephrol Dial Transplant 22: 1527-1536 [Abstract] [Full Text]
Shiroiwa, W., Tsukamoto, K., Ohtsuji, M., Lin, Q., Ida, A., Kodera, S., Ohtsuji, N., Nakamura, K., Tsurui, H., Kinoshita, K., Nishimura, H., Shirai, T., Hirose, S. (2007). IL-4R{alpha} polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus. Int Immunol 19: 175-183 [Abstract] [Full Text]
Zhang, C., Todorov, I., Zhang, Z., Liu, Y., Kandeel, F., Forman, S., Strober, S., Zeng, D. (2006). Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations. Blood 107: 2993-3001 [Abstract] [Full Text]
Forestier, C., Molano, A., Im, J. S., Dutronc, Y., Diamond, B., Davidson, A., Illarionov, P. A., Besra, G. S., Porcelli, S. A. (2005). Expansion and Hyperactivity of CD1d-Restricted NKT Cells during the Progression of Systemic Lupus Erythematosus in (New Zealand Black x New Zealand White)F1 Mice. J. Immunol. 175: 763-770 [Abstract] [Full Text]
Jury, E C, Ehrenstein, M R (2005). Statins: immunomodulators for autoimmune rheumatic disease?. Lupus 14: 192-196 [Abstract]
Yamauchi, T., Ishibashi, A., Shikata, K., Tokuhara, N., Seino, K.-i., Kobayashi, S., Nagai, M. (2005). Effect of E6060 [4-{5-[7-Fluoro-4-(trifluoromethyl)benzo[b]furan-2-yl]-1H-2-pyrrolyl}benzoic Acid], a Novel Subtype-Selective Retinoid, on Lupus-Like Nephritis in Female (NZBxNZW)F1 Mice. J. Pharmacol. Exp. Ther. 312: 938-944 [Abstract] [Full Text]
Lawman, S., Mauri, C., Jury, E. C., Cook, H. T., Ehrenstein, M. R. (2004). Atorvastatin Inhibits Autoreactive B Cell Activation and Delays Lupus Development in New Zealand Black/White F1 Mice. J. Immunol. 173: 7641-7646 [Abstract] [Full Text]
Kinoshita, K., Yamagata, T., Nozaki, Y., Sugiyama, M., Ikoma, S., Funauchi, M., Kanamaru, A. (2004). Blockade of IL-18 Receptor Signaling Delays the Onset of Autoimmune Disease in MRL-Faslpr Mice. J. Immunol. 173: 5312-5318 [Abstract] [Full Text]
Schmidt, K N, Ouyang, W (2004). Targeting interferon-{alpha}: a promising approach for systemic lupus erythematosus therapy. Lupus 13: 348-352 [Abstract]
Wajed, J., Ahmad, Y., Durrington, P. N., Bruce, I. N. (2004). Reply. Rheumatology (Oxford) 43: 398-399 [Full Text]
Jacob, C. O., Zang, S., Li, L., Ciobanu, V., Quismorio, F., Mizutani, A., Satoh, M., Koss, M. (2003). Pivotal Role of Stat4 and Stat6 in the Pathogenesis of the Lupus-Like Disease in the New Zealand Mixed 2328 Mice. J. Immunol. 171: 1564-1571 [Abstract] [Full Text]
Uhm, W.-S., Na, K., Song, G.-W., Jung, S.-S., Lee, T., Park, M.-H., Yoo, D.-H. (2003). Cytokine balance in kidney tissue from lupus nephritis patients. Rheumatology (Oxford) 42: 935-938 [Abstract] [Full Text]
Ramos, M A., Pinera, C., Setien, M A., Buelta, L., de Cos, M A., de Francisco, A.-L. M., Merino, R., Arias, M. (2003). Modulation of autoantibody production by mycophenolate mofetil: effects on the development of SLE in (NZBxNZW)F1 mice. Nephrol Dial Transplant 18: 878-883 [Abstract] [Full Text]
Sthoeger, Z M, Zinger, H, Mozes, E (2003). Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies. Ann Rheum Dis 62: 341-346 [Abstract] [Full Text]
Baechler, E. C., Batliwalla, F. M., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M., Kapur, V., Gregersen, P. K., Behrens, T. W. (2003). Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 100: 2610-2615 [Abstract] [Full Text]
Zinger, H., Eilat, E., Meshorer, A., Mozes, E. (2003). Peptides based on the complementarity-determining regions of a pathogenic autoantibody mitigate lupus manifestations of (NZB x NZW)F1 mice via active suppression. Int Immunol 15: 205-214 [Abstract] [Full Text]
Carvalho-Pinto, C. E., Garcia, M. I., Mellado, M., Rodriguez-Frade, J. M., Martin-Caballero, J., Flores, J., Martinez-A, C., Balomenos, D. (2002). Autocrine Production of IFN-{gamma} by Macrophages Controls Their Recruitment to Kidney and the Development of Glomerulonephritis in MRL/lpr Mice. J. Immunol. 169: 1058-1067 [Abstract] [Full Text]
Miyake, K., Nakashima, H., Akahoshi, M., Inoue, Y., Nagano, S., Tanaka, Y., Masutani, K., Hirakata, H., Gondo, H., Otsuka, T., Harada, M. (2002). Genetically determined interferon-{gamma} production influences the histological phenotype of lupus nephritis. Rheumatology (Oxford) 41: 518-524 [Abstract] [Full Text]
Esfandiari, E., McInnes, I. B., Lindop, G., Huang, F.-P., Field, M., Komai-Koma, M., Wei, X.-q., Liew, F. Y. (2001). A Proinflammatory Role of IL-18 in the Development of Spontaneous Autoimmune Disease. J. Immunol. 167: 5338-5347 [Abstract] [Full Text]
Kim, S. H., Kim, S., Evans, C. H., Ghivizzani, S. C., Oligino, T., Robbins, P. D. (2001). Effective Treatment of Established Murine Collagen-Induced Arthritis by Systemic Administration of Dendritic Cells Genetically Modified to Express IL-4. J. Immunol. 166: 3499-3505 [Abstract] [Full Text]
Khalil, M., Inaba, K., Steinman, R., Ravetch, J., Diamond, B. (2001). T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus. J. Immunol. 166: 1667-1674 [Abstract] [Full Text]
Eilat, E., Dayan, M., Zinger, H., Mozes, E. (2001). The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 98: 1148-1153 [Abstract] [Full Text]
Kono, D. H., Balomenos, D., Park, M. S., Theofilopoulos, A. N. (2000). Development of Lupus in BXSB Mice Is Independent of IL-4. J. Immunol. 164: 38-42 [Abstract] [Full Text]
Venkatraman, J. T., Chu, W.-c. (1999). Effects of Dietary {omega}-3 and {omega}-6 Lipids and Vitamin E on Serum Cytokines, Lipid Mediators and Anti-DNA Antibodies in a Mouse Model for Rheumatoid Arthritis. J. Am. Coll. Nutr. 18: 602-613 [Abstract] [Full Text]
Zavala, F., Masson, A., Hadaya, K., Ezine, S., Schneider, E., Babin, O., Bach, J.-F. (1999). Granulocyte-Colony Stimulating Factor Treatment of Lupus Autoimmune Disease in MRL-lpr/lpr Mice. J. Immunol. 163: 5125-5132 [Abstract] [Full Text]
Matthys, P., Vermeire, K., Mitera, T., Heremans, H., Huang, S., Schols, D., De Wolf-Peeters, C., Billiau, A. (1999). Enhanced Autoimmune Arthritis in IFN-{gamma} Receptor-Deficient Mice Is Conditioned by Mycobacteria in Freund's Adjuvant and by Increased Expansion of Mac-1+ Myeloid Cells. J. Immunol. 163: 3503-3510 [Abstract] [Full Text]
Kuroiwa, T., Lee, E. G., Danning, C. L., Illei, G. G., McInnes, I. B., Boumpas, D. T. (1999). CD40 Ligand-Activated Human Monocytes Amplify Glomerular Inflammatory Responses Through Soluble and Cell-to-Cell Contact-Dependent Mechanisims. J. Immunol. 163: 2168-2175 [Abstract] [Full Text]
Kuroiwa, T, Lee, E G (1998). Cellular interactions in the pathogenesis of lupus nephritis: The role of T cells and macrophages in the amplification of the inflammatory process in the kidney. Lupus 7: 597-603 [Abstract]
Wither, J., Vukusic, B. (1998). Autoimmunity Develops in Lupus-Prone NZB Mice Despite Normal T Cell Tolerance. J. Immunol. 161: 4555-4562 [Abstract] [Full Text]
Melrose, J., Tsurushita, N., Liu, G., Berg, E. L. (1998). IFN-{gamma} Inhibits Activation-Induced Expression of E- and P-Selectin on Endothelial Cells. J. Immunol. 161: 2457-2464 [Abstract] [Full Text]
Lauwerys, B R, Houssiau, F A (1998). Cytokines: clues to the pathogenesis of SLE. Lupus 7: 211-213
Haas, C., Ryffel, B., Le Hir, M. (1998). IFN-{gamma} Receptor Deletion Prevents Autoantibody Production and Glomerulonephritis in Lupus-Prone (NZB NZW)F1 Mice. J. Immunol. 160: 3713-3718 [Abstract] [Full Text]
Zeng, D., Dick, M., Cheng, L., Amano, M., Dejbakhsh-Jones, S., Huie, P., Sibley, R., Strober, S. (1998). Subsets of Transgenic T Cells That Recognize CD1 Induce or Prevent Murine Lupus: Role of Cytokines. JEM 187: 525-536 [Abstract] [Full Text]
Peng, S. L., Moslehi, J., Robert, M. E., Craft, J. (1998). Perforin Protects Against Autoimmunity in Lupus-Prone Mice. J. Immunol. 160: 652-660 [Abstract] [Full Text]
Seery, J. P., Carroll, J. M., Cattell, V., Watt, F. M. (1997). Antinuclear Autoantibodies and Lupus Nephritis in Transgenic Mice Expressing Interferon {gamma} in the Epidermis. JEM 186: 1451-1459 [Abstract] [Full Text]
Santiago, M.-L., Fossati, L., Jacquet, C., Muller, W., Izui, S., Reininger, L. (1997). Interleukin-4 Protects against a Genetically Linked Lupus-like Autoimmune Syndrome. JEM 185: 65-70 [Abstract] [Full Text]
Huang, S, Hendriks, W, Althage, A, Hemmi, S, Bluethmann, H, Kamijo, R, Vilcek, J, Zinkernagel, R., Aguet, M (1993). Immune response in mice that lack the interferon-gamma receptor. Science 259: 1742-1745 [Abstract]
Steinberg, A. D., Gourley, M. F., Klinman, D. M., Tsokos, G. C., Scott, D. E., Krieg, A. M. (1991). Systemic Lupus Erythematosus. ANN INTERN MED 115: 548-559 [Abstract]
Sinha, A., Lopez, M., McDevitt, H. (1990). Autoimmune diseases: the failure of self tolerance. Science 248: 1380-1388 [Abstract]
Todd, J., Acha-Orbea, H, Bell, J., Chao, N, Fronek, Z, Jacob, C., McDermott, M, Sinha, A., Timmerman, L, Steinman, L, et, al. (1988). A molecular basis for MHC class II--associated autoimmunity. Science 240: 1003-1009 [Abstract]